There is one word that runs through Patient Affairs: participation. Not as a slogan, not as an abstract principle, but as a daily practice, a concrete commitment to building bridges between the world of patients and that of institutions, research and digital health.
An approach in which advocacy becomes system infrastructure and, like every infrastructure, requires design, method and a clear vision of what needs to be built.
Participation as Method
Every healthcare system that aspires to sustainability must be grounded in an authentic understanding of the needs of those who navigate it. In practical terms, this means integrating patient experience into the definition of care pathways, informational materials, digital solutions and market access strategies, not downstream as validation, but upstream as a generative contribution to the decision-making process.
Co-design is the condition for effectiveness: a structured framework, built on empathy, creativity and interaction, to design solutions that work because they emerge from real engagement with those who inhabit them. From this perspective, the patient ceases to be a user to be persuaded and becomes a partner to learn from.
Patient Affairs, with its advocacy, is not a statement of intent but an operational methodology that delivers measurable outcomes in terms of engagement, adherence and perceived quality of care.
Language as a Lever for Equity
Among the cultural battles that define the work of advocates, language stands as one of the most critical. Inaccessible information, a consent form that does not truly inform, a digital tool that excludes: each of these elements represents a barrier to equity that advocacy can and must help remove.
Patient ability, understood as the capacity to understand, choose and actively collaborate , thus becomes a genuine systemic lever, before it is ever an individual one.
Advocacy and Market Access: A Structural Link
Within the current regulatory and HTA landscape, the patient voice has gained an increasingly relevant and formally recognized role. Patient Reported Outcomes, the co-production of evidence, the participation of patient associations in defining research endpoints: these are all elements that advocacy, when practiced with competence and method, can bring to scale, generating scientific value and concretely shaping access pathways.
Supporting companies and institutions in building patient engagement strategies does not mean activating relationships with associations as a communication lever. It means building structured co-design processes, grounded in a deep understanding of patients' real needs and in a credible institutional presence at decision-making tables.
It means a model of cultural advocacy founded on dialogue, active participation and a philosophy of value centered on the person , one that translates into concrete tools in support of corporate strategies for market access, public affairs and patient engagement.
Science, Philosophy and Institutions: the three pillars of the patient model
The advocacy supported by Patient Affairs is articulated across three complementary dimensions.
The first is scientific: the patient's voice must be able to produce evidence, not only narratives.
The second is philosophical: those who live with illness generate a knowledge that the clinical system cannot produce from within; integrating it is not an empathic gesture, but an act that enriches and sometimes corrects scientific knowledge.
The third is institutional: advocacy that does not enter the rooms where decisions are made, remains marginal.
Patient advocacy, in this vision, is the driver of the patient world and the added value of every process in which patient and professional build together.
A matter of Patient Affairs, always, of course.